of qSOFA was qSOFA AUC ¼ 0.69 (<0.001). The composite outcome was better predicted by NEWS with a AUC ¼ 0.77 (P<.001) and again poorly by the other scoring systems (qSOFA ¼ 0.69, P<0.001). The pairwise comparisons for composite outcome and 30-day mortality between qSOFA versus NEWS were statistically significant (P <0.008).
Study Objectives: We examined the incidence trend of sepsis over 11 years and compared mortality outcomes among patients with sepsis admitted from emergency department (ED) and non ED routes.
Methods: We used a nationwide health insurance database, which comprise of 23 million beneficiaries. Patients with sepsis were identified by ICD-9 CM codes for infection and organ dysfunction from 2002 to 2012. We performed propensity score matching and compared mortality rates between ED-admitted and non ED-admitted patients.
Results: During the 11-year study period, we identified 1,256,684 patients with sepsis. 493,397 (29.3%) were admitted through the ED, and 763,287 (70.7%) were admitted directly to the floor. The frequency of ED-admitted hospitalizations for sepsis increased from 237.3/100,000 person-year to 369.6/100,000 person-year (5.06% annual increase), while that of directly admitted patients remained relatively unchanged. Although patients with sepsis admitted through the ED had a higher incidence of organ dysfunction than patients who were directly admitted, they had more favorable outcomes in mortality, length of ICU stay, and hospital stay. After propensity score matching, ED-admitted patients had a 7% lower risk of 90-day mortality (HR, 0.93, 95% CI, 0.89-0.97) compared to directly admitted patients.
Conclusions: During the study period, mortality from sepsis declined faster among patients admitted from the emergency department compared to the mortality of patients admitted directly to the floor. Patients with sepsis who were admitted through the ED were also associated with a decreased risk of 90-day mortality. Study Objectives: Recent studies have shown synovial lactate to be a promising biomarker when it comes to distinguishing between septic and aseptic joints. This study utilizes the EPOC point-of-care analyzer to obtain synovial lactate values in order to test the efficacy of synovial lactate in the rapid identification of septic joints in an emergency department setting.
Methods: Patients presenting to the emergency department at a large urban academic center, between October 2016 and April 2018, were prospectively enrolled in a convenience sample if their treating physician felt that arthrocentesis was necessary to assess for a septic joint. Values for synovial lactate were obtained using the point-of-care EPOC blood gas analysis system by Alere. The synovial fluid was also sent to the main laboratory for standard analysis and culture. These results, as well as the patient's emergency department and hospital course, any operative procedures done, antibiotics given, and discharge diagnosis were additionally abstracted from the electronic medical record.
Results: 39 patients and 40 separate joints were enrolled in this study over the 2-year period. Eleven of the 39 patients were female (28%) and the patients ranged in age from 16 to 85 years, with a mean of 51 years. There was no significant difference in diagnosis of septic joint by sex (p ¼ 0.82) or by age (p ¼ 0.60). The sensitivity and specificity of a synovial lactate level 5 mmol/L was 0.55 and 0.76 respectively, with LR + 2.3 and LR -0.6. The sensitivity and specificity of a synovial lactate level 10 mmol/L was 0.27 and 0.97 respectively, with LR + 7.9 and LR -0.8. Synovial lactate 10 mmol/L performed similarly to an overall synovial WBC count 50,000. Given the small sample size of the study, statistical significance was not reached, and further evaluation is necessary to conclusively determine the effectiveness of synovial lactate in differentiating between septic and aseptic arthritis.
Conclusions: Compared with other markers classically used, point-of-care synovial lactate appears to provide an adequate, though not ideal, assessment for the septic joint. However, due to the small sample size of this study, further evaluation is needed. Study Objectives: Renal stones can be caused by bacteria (infectious stones) or can be secondarily infected (stones with a UTI), leading to a septic stone/sepsis. White cells on urinalysis may indicate infection or ureteral inflammation. There is a wide practice pattern of emergency physicians and urologists when treating pyuria associated with renal stones, with no studies to help in determining which patients may have an infection. The goal of this study is to analyze urine results in renal colic patients (confirmed by CT) with culture proven (uCLX) intercurrent infections. Such analysis could help risk-stratify patients more accurately for admission/antibiotic treatment.
Methods: We performed a retrospective study examining vital signs, demographics, but concentrating on UA and urine culture results to determine if patients with infectious stones, or stones with infection, can be identified by simple UA. Data was extracted from an electronic charting system from a suburban medical center with an adult/pediatric volume over 90k visits/yr. Appropriate statistical test with a significant p of <0.05 were performed including backward stepwise GLM. Patients > 21 years of age with an ICD9/10 diagnosis of renal colic (confirmed by CT) between 1/3/2014 and 4/23/2015 were included.
Results: 375 charts were reviewed with 261 having a CT-confirmed stone (data missing for analysis indicated by numbers reported). 150 were men (57.5%). Median age was 53.4 (95% CI 51.2 to 55.4; IQR 43.2 to 62.4). 33 patients (12.6%) were +uCLX at > 10,000 CFU. There was a significant difference with regards to a +uCLX versus -uCLX based on sex (females 20/111 versus males 13/ 150; difference of proportion -0. 
